Aoyama Zaisan Networks Company,Limited Logo

Aoyama Zaisan Networks Company,Limited

Consulting on inheritance and business succession for individuals and corporations.

8929 | T

Overview

Corporate Details

ISIN(s):
JP3825750007
LEI:
Country:
Japan
Address:
港区赤坂八丁目4番14号青山タワープレイス3階
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Aoyama Zaisan Networks Company, Limited is a Japanese consulting firm specializing in comprehensive property and asset management solutions. The company primarily offers two types of services: inheritance consulting for individual asset owners and business succession consulting for corporations. It leverages its expertise in real estate, financial products, and related services to provide tailored solutions for asset transfer, maintenance, and operations. The firm's service portfolio also includes real estate solutions and property investment support in the USA.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-07 08:32
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-08-07 08:31
Interim Report
半期報告書-第35期(2025/01/01-2025/12/31)
Japanese 201.7 KB
2025-06-11 06:18
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 24.3 KB
2025-05-09 05:53
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.7 KB
2025-04-07 03:24
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.7 KB
2025-03-27 07:51
Registration Form
確認書
Japanese 8.2 KB
2025-03-27 07:51
Governance Information
内部統制報告書-第34期(2024/01/01-2024/12/31)
Japanese 22.0 KB
2025-03-27 07:50
Annual Report
有価証券報告書-第34期(2024/01/01-2024/12/31)
Japanese 2.0 MB
2025-03-27 07:46
Post-Annual General Meeting Information
臨時報告書
Japanese 23.4 KB
2025-03-10 08:44
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.7 KB
2025-02-10 07:56
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.7 KB
2025-01-15 08:52
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 24.1 KB
2024-12-12 06:15
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.9 KB
2024-11-14 08:01
M&A Activity
臨時報告書
Japanese 64.0 KB
2024-08-08 08:03
Report Publication Announcement
確認書
Japanese 8.1 KB

Automate Your Workflow. Get a real-time feed of all Aoyama Zaisan Networks Company,Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Aoyama Zaisan Networks Company,Limited

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Aoyama Zaisan Networks Company,Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland CTX
Cardiff Oncology, Inc. Logo
Clinical-stage biotech developing a PLK1 inhibitor to treat resistant cancers.
United States of America CRDF
Cardio Diagnostics Holdings, Inc. Logo
AI-powered epigenetic and genetic tests for early detection of heart disease risk.
United States of America CDIO
Cardiol Therapeutics Inc. Logo
Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.
United States of America CRDL
CareDx, Inc. Logo
Precision diagnostics and surveillance solutions for the organ transplant journey.
United States of America CDNA
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan 6070
Caris Life Sciences, Inc. Logo
Pioneering precision cancer care via AI-powered molecular profiling and diagnostics.
United States of America CAI
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan 4572
CARTA HOLDINGS, INC. Logo
Digital marketing firm offering ad platforms and integrated solutions to empower businesses.
Japan 3688

Talk to a Data Expert

Have a question? We'll get back to you promptly.